IL1RAP is an emerging target in chronic airway inflammatory diseases
G. Kasetty (Mölndal, Sweden), M. Jönsson (Mölndal, Sweden), J. Persson (Mölndal, Sweden), P. Grundevik (Mölndal, Sweden), J. Nys (Granta Park, United Kingdom), S. Cohen (Granta Park, United Kingdom), A. Borde (Granta Park, Sweden), M. Birrell (London, United Kingdom)
Source: International Congress 2022 – Translational studies of asthma and COPD
Session: Translational studies of asthma and COPD
Session type: Thematic Poster
Number: 4310
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Kasetty (Mölndal, Sweden), M. Jönsson (Mölndal, Sweden), J. Persson (Mölndal, Sweden), P. Grundevik (Mölndal, Sweden), J. Nys (Granta Park, United Kingdom), S. Cohen (Granta Park, United Kingdom), A. Borde (Granta Park, Sweden), M. Birrell (London, United Kingdom). IL1RAP is an emerging target in chronic airway inflammatory diseases. 4310
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|